"The DOJ officially moved marijuana to Schedule III, placing it alongside drugs like ketamine and certain steroids instead of heroin or LSD. That's not legalization - but it's a meaningful policy shift."
"Reclassification doesn't legalize marijuana federally - states still operate under a patchwork of laws. But it does remove one major obstacle: IRS Code Section 280E."
"Moving to Schedule III allows normal corporate tax treatment - typically 21% federally. That's a direct hit to the bottom line - and a positive one."
"The market reaction came fast: Tilray Brands rose 14%, Canopy Growth climbed 21%, and Aurora Cannabis was up a more muted 6.7%. All three stocks are lower in midday trading, down mid- to high-single-digits."
The DOJ's reclassification of marijuana to Schedule III signifies a notable policy change, allowing cannabis companies to deduct ordinary business expenses. This shift does not legalize marijuana federally, as state laws remain varied. Initial market reactions included significant stock increases for major cannabis companies, but subsequent pullbacks indicate profit-taking by traders. While the reclassification reduces tax burdens and improves access to banking and capital, the overall market sentiment suggests ongoing challenges for sustained growth in the cannabis sector.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]